Camargo Pharmaceutical Services to acquire Canada-based InSymbiosis
Date: 2019-06-15   Author: Pankaj Singh  Category: #news

Camargo Pharmaceutical Services to acquire Canada-based InSymbiosis

Camargo Pharmaceutical Services, a leading drug development and commercialization service provider recently announced that it plans to acquire InSymbiosis, a Canada-based drug developer that enables biopharmaceutical companies to outsource research & development, cite sources.

The announcement came on the heels of an announcement made earlier this year by Camargo Pharmaceutical to expand its capabilities & global presence through acquisitions.

For the record, based in Montreal, Canada, InSymbiosis is managed by ex-pharma and contract research organization drug development executives and scientists. The company’s team includes financial and investment experts, a multidisciplinary drug development group and a competent project management team.

Dean Wenham, CEO, InSymbiosis was reported to say that the company started with a vision to build a mutual relationship across the healthcare landscape for pharmaceutical development. In partnership with Camargo, the synergy aims to deliver optimized development programs to clients and advance relationships across healthcare segment, Wenham added.

For the record, Camargo Pharmaceutical Services was founded in 2003 and is a global development & commercialization partner to large and small pharmaceutical companies. The company is known for its ability to provide life-changing therapies to clients, faster and more cost-effectively.

The company is established as a recognized expert & industry leader in designing complex, customized development strategies and focuses on client’s success. The client-base and global reach of Camargo extends to over more than 25 countries.

Dan Duffy, CEO, Camargo Pharmaceuticals was reportedly quoted saying that with the acquisition, the company will strengthen its ability to reach milestones & connect patients to life-changing therapies. InSymbiosis enables clients to optimize their clinical and non-clinical programs and provides excellent results.

Camargo Pharmaceuticals is better positioned in partnership with Insymbiosis to strengthen its efforts to deliver an industry-leading integrated drug development solution for the biotech and global pharma market, Duffy added.

Source credits: https://www.prnewswire.com/news-releases/camargo-pharmaceutical-services-enhances-drug-development-services-through-acquisition-of-montreal-based-insymbiosis-300866579.html



About Author


Pankaj Singh

Pankaj Singh

Pankaj Singh Develops content for Algosonline, Market Size Forecasters, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More from Pankaj


Post Recommendents

Baby Electronic Toys Industry Market to 2025: Growth Analysis by Manufacturers, Regions, Types and Applications
Author: Sachin Pashte

The qualitative research study now available with Market Study Report, LLC on Global Baby Electronic Toys Industry Market Report provides primary Data, surveys, Scope of the Product and vendor briefings. The market dynamic forces have been determi...


Speciality Coffee Industry Market Growth Prospects, Key Vendors, Future Scenario Forecast to 2025
Author: Sachin Pashte

The Speciality Coffee Industry Market report provides detailed competitive landscape of the global market. It includes company, market share analysis, product portfolio of the major industry participants. The report provides detailed segmentation ...


Compact Lidar Industry Market with Report In Depth Industry Analysis on Trends, Growth, Opportunities and Forecast till 2025
Author: Sachin Pashte

The demand for Global Compact Lidar Industry market is anticipated to be high for the next five years. By considering this demand we provide latest Global Compact Lidar Industry Market Report which gives complete industry analysis, market outlook,...